Latest filing published 16 Mar 2026 for Myriad Genetics INC.
This profile gathers the share dealings of Shereen Solaiman across 2 companies, led by Myriad Genetics Inc and Borders Group Inc. The record holds 12 filings, for trades running from 1 October 2009 to 14 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 March 2026: a share grant of €23k, in Myriad Genetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations